β Home
βΉοΈ Info
π§Ύ At a Glance π Core Facts ποΈ Products/Services β Ratings π§βπΌ Executives π¬ My Commentsπ‘ Analytics
π Insights π’ Company Q&A (663) π οΈ Industry Q&A (164) π Competitors π Price Low π Price Swings β‘ SWOT ποΈ PEST π Porter's Five Forces β¨ Score Positive β οΈ Risk Assessment π§© Segmentation π Ά Google Linksπ Ratios
π° Margins π Financial Ratios π± Growth π Enterprise Value π Key Metrics π΅ Dividendsπ§ Tools
β Due Diligenceπ’ Press Releases
| Date | Press release |
|---|---|
| 2026-05-12 16:05:00 | Cnb Financial Corporation Announces Quarterly Dividend For Common Stock Clearfield, pa., may 12, 2026 (globe newswire) -- the board of directors of cnb financial corporation (nasdaq: ccne) declared a quarterly cash dividend of $0.19 per share of common stock payable on june 15, 2026 to common stock shareholders of record as of june 1, 2026. |
| 2026-04-20 07:00:00 | Monte Rosa Therapeutics Presents Preclinical Data At American Association For Cancer Research (aacr) Annual Meeting 2026 On The Potential Of Its Cyclin E1 (ccne1)-directed Molecular Glue Degrader To Treat Ccne1-amplified Solid Tumors Ccne1-directed molecular glue degrader (mgd) induced deep tumor regressions in ccne1-amplified in vivo models of ovarian, breast, and gastric cancersΒ ccne1-directed mgd demonstrated superior selectivity and reduced off-target activity compared to cdk2 inhibitors oral presentation on april 21, 2026, at 2:30 p.m. pt boston, april 20, 2026 (globe newswire) -- monte rosa therapeutics, inc.Β (nasdaq: glue), a clinical-stage biotechnology company developing novel molecular glue degrader (mgd)-based medicines, today announced the company will present preclinical data highlighting the potential of its highly selective, first-in-class cyclin e1 (ccne1)-directed mgd, mrt-55811, to treat ccne1-amplified solid tumors at the american association for cancer research (aacr) annual meeting 2026, being held april 17-22 in san diego, ca. |
| 2026-04-14 16:05:00 | Cnb Financial Corporation Announces Quarterly Dividend For Series A Preferred Stock And Related Depositary Shares Distribution Clearfield, pa., april 14, 2026 (globe newswire) -- the board of directors of cnb financial corporation (nasdaq: ccne) (the βcorporationβ) has announced the declaration of a quarterly cash dividend of $0.4453125 per depositary share (nasdaq: ccnep), resulting from the corporationβs declaration of a quarterly cash dividend of $17.8125 per share on its series a preferred stock. the dividend is payable on june 1, 2026, to holders of record as of may 15, 2026. |
| 2026-02-18 16:05:00 | Cnb Bank Joins The Federal Reserve Bank Of Philadelphia As A State Member Bank Clearfield, pa., feb. 18, 2026 (globe newswire) -- cnb financial corporation (βcnbβ) (nasdaq: ccne) today announced that cnb bank, its wholly-owned banking subsidiary, became a state member bank regulated by the board of governors of the federal reserve system through the federal reserve bank of philadelphia effective february 12, 2026. cnb bank will also continue to be regulated by the pennsylvania department of banking and securities. |
| 2026-02-10 16:05:00 | Cnb Financial Corporation Announces Quarterly Dividend For Common Stock Clearfield, pa., feb. 10, 2026 (globe newswire) -- the board of directors of cnb financial corporation (nasdaq: ccne) declared a quarterly cash dividend of $0.19 per share of common stock payable on march 13, 2026 to common stock shareholders of record as of february 27, 2026. |
| 2026-01-27 16:05:00 |
|
| 2026-01-20 16:05:00 |
|
| 2025-11-12 16:05:00 |
|
| 2025-10-29 16:05:00 |
|
| 2025-08-12 16:05:00 |
|
| 2025-07-24 08:00:00 |
|
| 2025-07-22 16:05:00 |
|
| 2025-06-30 16:15:00 |
|
| 2025-06-30 16:05:00 |
|
| 2025-05-13 16:05:00 |
|
π° Browse additional press releases for CNB Financial!
Sign up for free or log inπ‘ Learn smarter stock picks with "The Checklist Value Investor β A Smarter Way to Pick Stocks"